Assessment of biomarkers in paired primary and recurrent colorectal adenocarcinomas

International Journal of Radiation Oncology Biology Physics

Volumn 45, Issue 5, 1999, Pages 1167-1173

  Seong, Jinsil ^a   Chung, Eun Ji ^a   Kim, Hogeun ^a   Kim, Gwi Eon ^a   Kim, Nam Kyu ^a   Sohn, Seung Kuk ^a   Min, Jin Sik ^a   Suh, Chang Ok ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

Apoptosis; Biomarker; Proliferation; Recurrent colorectal cancer

Indexed keywords

CYCLIN B1; CYCLIN D1; CYCLINE; PROTEIN P53;

ADENOCARCINOMA; ADULT; AGED; APOPTOSIS; ARTICLE; CANCER GROWTH; CELL LOSS; CELL PROLIFERATION; CLINICAL ARTICLE; COLORECTAL CARCINOMA; FEMALE; GENE EXPRESSION REGULATION; GENE FUNCTION; HUMAN; MALE; PRIORITY JOURNAL; PROGNOSIS; RECURRENT CANCER;

ADULT; AGED; APOPTOSIS; CDC2 PROTEIN KINASE; CELL DIVISION; COLONIC NEOPLASMS; CYCLIN B; CYCLIN D1; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; DNA FRAGMENTATION; FEMALE; HUMANS; IN SITU NICK-END LABELING; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROLIFERATING CELL NUCLEAR ANTIGEN; RECTAL NEOPLASMS; SIGMOID NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0345580321     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(99)00302-8     Document Type: Article

References (47)

1. Whiteley H.W., Stearn M.W., Leaming R.H., et al. Palliative radiation therapy in patients with cancer of the colon and rectum. Cancer. 25:1970;343-346.
2. Ciatto S., Cummings B.J., Wong C.S., et al. Radiation therapy of recurrence of carcinoma of the rectum and sigmoid after surgery. Acta Radiol Oncol. 21:1982;105-109.
3. Overgaard M., Overgaard J., Sell A. Dose-response relationship for radiation therapy of recurrent residual, and primarily inoperable colorectal cancer. Radiother Oncol. 1:1984;217-225.
4. Dobrowsky W., Schmid A.P. Radiotherapy of presacral recurrence following radical surgery for rectal carcinoma. Dis Colon Rectum. 28:1985;917-919.
5. Frykholm G.S., Pahlman L., Glimelins B. Treatment of local recurrences of rectal carcinoma. Radiother Oncol. 34:1995;185-194.
6. Wong C.S., Cummings B.J., Brierley J.D., et al. Treatment of locally recurrent rectal carcinoma Results and prognostic factors . Int J Radiat Oncol Biol Phys. 40:1998;428-435.
7. John M.J. Radiotherapy and chemotherapy. Leibel S.A., Phillips T.L. Textbook of radiation oncology. 1998;69-89 W. B. Saunders, Philadelphia.
8. Sheldon P.W., Begg A.G., Fowler J.F., et al. The incidence of lung metastases in C3H mice after treatment of implanted solid tumors with X-rays or surgery. Br J Cancer. 30:1974;342-348.
9. De Ruiter J., Cramer S.J., Lelieveld P., et al. Comparison of metastatic disease after local treatment with radiotherapy or surgery in various tumor models. Eur J Cancer Clin Oncol. 18:1982;281-289.
10. Suit H., Allam A., Allarunis-Turner J., et al. Is tumor cell radiation resistance correlated with metastatic ability? Cancer Res. 54:1994;1736-1741.
11. Deschner E. Kinetics of normal, preneoplastic, and neoplastic colonic epithelium. Moyer M.P., Poste G.H. Colon cancer cells. 1990;41-61 Academic Press, San Diego, CA.
12. Bedi A., Pasricha P., Akhtar A., et al. Inhibition of apoptosis during development of colorectal cancer. Cancer Res. 55:1995;1811-1816.
13. Tsujitani S., Shirai H., Tatebe S., et al. Apoptotic cell death and its relationship to carcinogenesis in colorectal carcinoma. Cancer. 77:1996;1711-1716.
14. Hashimoto S., Koji T., Kohara N., et al. Frequency of apoptosis related inversely to invasiveness and metastatic activity in human colorectal cancer. Virchows Arch. 431:1997;241-248.
15. Symonds H., Krall L., Remington L., et al. p53-dependent apoptosis suppresses tumor growth and progression in vivo. Cell. 78:1994;703-708.
16. Wyllie A.H. Apoptosis. Br J Cancer. 67:1993;205-209.
17. Ellis R.E., Yuan J., Horvitz R.H. Mechanisms and functions of cell death. Annu Rev Cell Biol. 7:1991;663-698.
18. Kerr J.F.R., Wyllie A.H., Currie A.R. Apoptosis A basic biological phenomenon with wide ranging implications in tissue kinetics . Br J Cancer. 26:1972;239-257.
19. Martz E., Howell D.M. CTL Virus controls cells first and cytolytic cells second? Immunol Today. 10:1989;79-86.
20. Williams G.T. Programmed cell death Apoptosis and oncogenesis . Cell. 65:1991;1097-1098.
21. Fan S., El-Deiry S., Bae I., et al. p53 gene mutations are associated with decreased sensitivity of human lymphoma cells to DNA damaging agents. Cancer Res. 54:1994;5824-5830.
22. Tsang N.M., Nagasawa H., Li C., et al. Abrogation of p53 function by transfection of HPV 16 E6 gene enhances the resistance of human diploid fibroblasts to ionizing radiation. Oncogene. 10:1995;2403-2408.
23. Namba H., Hara T., Tukazaki T., et al. Radiation-induced G1 arrest is selectively mediated by the p53-WAF1/CIP1 pathway in human thyroid cells. Cancer Res. 55:1995;2075-2080.
24. Lowe S.W., Bodis S., McClatchey A., et al. Altered p53 status and the efficacy of cancer therapy in vivo. Science. 266:1994;807-810.
25. Smith M.L., Chen I.T., Zhan Q., et al. Involvement of p53 tumor suppressor in repair of u.v.-type DNA damage. Oncogene. 10:1995;1053-1059.
26. McKinnon P.J. Ataxia-telangiectasia An inherited disorder of ionizing radiation sensitivity in man . Hum Genet. 75:1987;197-208.
27. Maity A., McKenna W.G., Muschel R.J. The molecular basis for cell cycle delays following ionizing radiation A review . Radiother Oncol. 31:1994;1-13.
28. Hartwell L.H., Kastan M.B. Cell cycle control and cancer. Science. 266:1994;1821-1828.
29. Xiong Y., Zhang H., Beach D. D type cyclins associate with multiple protein kinases and the DNA replication and repair factor PCNA. Cell. 71:1992;505-514.
30. Waldman T., Kinzler K.W., Vogelstein B. p21 is necessary for the p53-mediated G1 arrest in human cancer cells. Cancer Res. 55:1995;5187-5190.
31. Maity A., Kao G.D., Muschel R.J., et al. Potential molecular targets for manipulating the radiation response. Int J Radiat Oncol Biol Phys. 37:1997;639-653.
32. Gavrieli Y., Sherman Y., Ben-Sasson S.A. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol. 119:1992;493-501.
33. Fearson E.R., Vogelstein B. A genetic model for colorectal tumorigenesis. Cell. 61:1990;759-767.
34. Remvikos Y., Tominaga O., Hammel P., et al. Increased p53 protein content of colorectal tumors correlates with poor survival. Br J Cancer. 66:1992;758-764.
35. Tominaga O., Hamelin R., Trouvat V., et al. Frequently elevated content of immunochemically defined wild-type p53 protein in colorectal adenomas. Oncogene. 8:1993;2653-2658.
36. Iggo R., Gatter K., Bartek J., et al. Increased expression of mutant forms of p53 oncogene in primary lung cancer. Lancet. 335:1990;675-679.
37. Gannoy J.V., Greaves R., Iggo R., et al. Activating mutations in p53 produce a common conformational effect A monoclonal antibody specific for the mutant form . EMBO J. 39:1990;1595-1602.
38. Bertorelle R., Esposito G., DelMistro A., et al. Association of p53 gene and protein alterations with metastases in colorectal cancer. Am J Surg Pathol. 19:1995;463-471.
39. Tannapfel A., Nublein S., Fietkau R., et al. Apoptosis, proliferation, bax, bcl-2, and p53 status prior to and after preoperative radiochemotherapy for locally advanced rectal cancer. Int J Radiat Oncol Biol Phys. 41:1998;585-591.
40. El-Deiry S., Harper J.W., O'Connor P.M., et al. WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis. Cancer Res. 54:1994;1169-1174.
41. Bae I, Fan S, Bhatia KB; et al. Relationships between G1 arrest and stability of the p53 and p21 CIP1/WAF1 proteins following irradiation of human lymphoma cells. Cancer Res 1995;55:2387-233.
42. Fu C., Tominaga O., Nagawa H., et al. Role of p53 and p21/WAF detection in patients selection for preoperative radiotherapy in rectal cancer patients. Dis Colon Rectum. 41:1998;68-74.
43. Michalides R., van Veelen N., Hart A., et al. Overexpression of cyclin D1 correlates with recurrence in a group of forty-seven operable squamous cell carcinomas of the head and neck. Cancer Res. 55:1995;975-978.
44. Naitoh H., Shibata J., Awaguchi A., et al. Overexpression and localization of cyclin D1 mRNA and antigen in esophageal cancer. Am J Pathol. 146:1995;1161-1169.
45. Maeda K., Chung Y., Kang S., et al. Overexpression of cyclin D1 and p53 associated with disease recurrence in colorectal adenocarcinoma. Int J Cancer. 74:1997;310-315.
46. Cohen-Jonathan E., Toulas C., Rochaix P., et al. Preferential cytoplasmic localization of p34cdc2 in recurrent human squamous cell carcinoma after radiotherapy. Rad Res. 147:1997;277-283.
47. Trzepacz C., Lowy A.M., Kordich J.J., et al. Phosphorylation of the tumor suppressor adenomatous polyposis coli (APC) by the cyclin-dependent kinase p34. J Biol Chem. 272:1997;12681-21684.